NCT04633109

Brief Summary

The sense of taste is essential for priming food preferences and is therefore important for caloric uptake and body weight regulation. Recent studies show that obesity is linked to changes in taste sensation but also to a loss of taste buds on the tongue. This study aims to evaluate underlying mechanisms within the taste buds to potentially influence the sense of taste on the level of these sensory cells and in order to develop new treatment strategies to fight obesity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

November 9, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 18, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

January 14, 2021

Status Verified

January 1, 2021

Enrollment Period

1.7 years

First QC Date

November 6, 2020

Last Update Submit

January 13, 2021

Conditions

Keywords

Obesityfood preferencestaste disordertaste budmetabolic diseasefeeding behavior

Outcome Measures

Primary Outcomes (2)

  • Identification of differential gene and protein regulation in isolated human taste cells between lean and obese subjects

    Transcriptomics (RNAsequencing (seq), single cell seq) and epigenomics (open chromatin mapping (ATACseq), Infinium MethylationEPIC Array) will be performed in isolated papillae fungiformes. Validation analyses by in vitro primary cell cultures of taste cell biopsy

    through study completion, an average of 2 years

  • Identification of correlations between taste cell biology with parameters of intervention

    corrleation analyses will include factors of eating behavior, food preferences, life style factors, data from taste and smell screenings, anthropometric data, blood and saliva parameters

    1 year

Secondary Outcomes (2)

  • Differences of salivary and tongue microbiome on taste cells in obesity in contrast to lean

    2 years

  • extracellular vesicle analyses of saliva in lean and obese subjects

    2 years

Study Arms (2)

normal weight

Normal weight adults with BMI ranging from 18.5-24.9; men and women; age range 18-69years; written informed consent

Procedure: taste bud biopsyDiagnostic Test: oral glucose tolerance testDiagnostic Test: Taste sensitivityDiagnostic Test: olfactory functionDiagnostic Test: taste bud densityDiagnostic Test: anthropometryOther: biospecimen collectionOther: questionnaires

obese

Subjects with obesity as defined by BMI \>= 30; men and women; age range 18-69 years; written informed consent

Procedure: taste bud biopsyDiagnostic Test: oral glucose tolerance testDiagnostic Test: Taste sensitivityDiagnostic Test: olfactory functionDiagnostic Test: taste bud densityDiagnostic Test: anthropometryOther: biospecimen collectionOther: questionnaires

Interventions

Taste buds will be surgically removed a) during a planned and medically induced elective surgery under full anesthesia; b) by local anesthesia in subjects without a medically induced surgery

normal weightobese

75g glucose will be applied in drinking water following blood sample collection to evaluate glucose, insulin and C-peptide level.

normal weightobese
Taste sensitivityDIAGNOSTIC_TEST

Subjects are given taste strips with 4 concentrations per each taste quality of sweet, sour, salty, bitter and umami in a pseudo-randomized manner. Subjects are asked to identify the taste quality, state the intensity, preference and certainty.

normal weightobese
olfactory functionDIAGNOSTIC_TEST

Subjects will be presented 16 different sniffing sticks in a randomized order, each for about 4seconds. People are then asked to identify the smell by choosing one out of 4 options (forced choice).

normal weightobese
taste bud densityDIAGNOSTIC_TEST

The number of taste buds on the anterior tongue will be determined by colouring the tongue surface with food colour. Taste buds will apply more reddish as compared to non-taste tissue. Based on a digital photography the number of taste buds per subjects is counted manually.

normal weightobese
anthropometryDIAGNOSTIC_TEST

Anthropometric data collection will include measures of body height, body weight, arm-, upper- and lower leg circumferences, waist- and hip circumferences and a bioimpedance analysis to obtain data about body composition.

normal weightobese

Blood and saliva samples will be taken as well as a tongue swab.

normal weightobese

Through the use of several questionnaires, data about eating behavior, food preferences, life style factors and other will be obtained.

normal weightobese

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

the study population will mainly consits of patients who underwent a medically induced elective surgery at the head or neck area (f.e. surgery at the soft palate, plastic surgery, maintenance of congenital anomalies etc.) or healthy participants recruited elsewhere at the campus area of the Medical Faculty of the University of Leipzig, Saxony, Germany.

You may qualify if:

  • normal weight (BMI 18.5-24.9)
  • obesity (BMI \>=30)
  • overall healthy (no severe sickness, no cancer)
  • written informed consent

You may not qualify if:

  • current pregnancy or currently breastfeeding
  • cancer or tumors
  • state after radiotherapy at head-neck area
  • state after or current chemotherapy
  • severe psychiatric-, cardiac-, kidney- or neurological illness
  • diagnosed diabetes mellitus
  • known dysfunction of smelling or tasting
  • drug or alcohol abuse
  • permanent medication with antidepressants, anticonvulsants, steroids and/or immunosuppressants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Clinic III, Division of Endocrinology, University Clinic of Leipzig

Leipzig, Saxony, 04103, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Taste buds, saliva, blood

MeSH Terms

Conditions

ObesityFood PreferencesTaste DisordersMetabolic DiseasesFeeding Behavior

Interventions

Glucose Tolerance TestAnthropometrySurveys and Questionnaires

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorSensation DisordersNeurologic ManifestationsNervous System DiseasesBehavior, Animal

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineInvestigative TechniquesPhysical ExaminationBiometryEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Michael Stumvoll, Prof. Dr.

    Medical Faculty of the University of Leipzig, Leipzig, Germany

    STUDY DIRECTOR
  • Imke Schamarek, Dr.

    Medical Faculty of the University of Leipzig, Leipzig, Germany

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Scientist

Study Record Dates

First Submitted

November 6, 2020

First Posted

November 18, 2020

Study Start

November 9, 2020

Primary Completion

July 15, 2022

Study Completion

July 30, 2022

Last Updated

January 14, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

one aim of this study is to obtain large-scale sequencing data. with this several not yet defined research questions will be generated which shall be explored through later analyses and projects. in order to exploit the potential of the data and to avoid misinterpretation, the data should only be accessible to the scientists and collaborators involved.

Locations